Journal of Vascular Medicine & Surgery

Department of Nuclear Medicine, Tours University Hospital, Tours, France

Biography

Dr. Maxime Courtehoux is a specialist in nuclear medicine at the Tours University Hospital in Tours, France. He practices at the CHRU Bretonneau and CHRU Trousseau hospitals, located at 2 Boulevard Tonnelle, 37044 Tours, and Avenue de la République, 37170 Chambray-lès-Tours, respectively. Dr. Courtehoux has contributed to several research studies in his field. Dr. Courtehoux's has expertise and ongoing contributions to advancements in nuclear medicine.

Publications

• Research Article   
  Mobiderm® Autofit Garments for Reducing Lower Limb Lymphedema: A Single-Arm Study Exploring Underlying Mechanisms
  Author(s): Loic Vaillant*, Valerie Tauveron and Maxime Courtehoux
  
  Background: Lymphedema is a chronic, disabling condition that results from a dysfunctional lymphatic system. The Mobiderm® Autofit device is designed to apply pressure and mobilize lymph to reduce edema and prevent worsening. This study aimed to identify the mechanisms that underlie the limb volume improvements and skin changes that are seen when using the device. Methods: In this single-center exploratory study, patients who had lower limb lymphedema (stage II/III) wore a thigh-high Mobiderm® Autofit device for 48 hours of intensive treatment. Measurements were obtained on Day 1 (D1) and Day 3 (D3) using lymphoscintigraphy, high-frequency ultrasound, a cutometer, and volume calculations. Results: Nine patients (aged 28-72 years) were included. The mean volume of the treated limb fell .. View more»
  

  DOI: 10.35248/2329-6925.24.12.565

  Abstract HTML PDF

Other relevant publications from this author

• 1. Myocardial Flow Reserve Measurement During CZT-SPECT Perfusion Imaging for Coronary Artery Disease Screening: Correlation With Clinical Findings and Invasive Coronary Angiography—The CFR-OR Study
  2. A study protocol for an observational cohort investigating cardiac transthyretin amyloidosis flow reserve before and after Tafamidis treatment: The AMYTRE study
  3. Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow measurement reproducibility during CZT-SPECT myocardial perfusion imaging
  4. Precision of Myocardial Blood Flow and Flow Reserve Measurement During CZT SPECT Perfusion Imaging Processing: Intra- and Interobserver Variability